EGFR and non-small cell lung carcinoma: Aberrant overexpression of the epidermal growth factor receptor (EGFR) has been detected in various malignancies, including nonsmall cell lung cancer (NSCLC), colorectal cancer (CRC), and head and neck squamous cell carcinoma (HNSCC), and is associated with a poor prognosis [1,2,3].